Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol regulatory element-binding protein 1-c (SREBP-1c) is a transcription factor primarily regulating genes involved in lipid (especially fatty acid) and cholesterol biosynthesis. Encoded by the SREBF1 gene, SREBP-1c arises from alternative promoter usage distinct from the related isoform SREBP-1a. SREBP-1c is predominantly expressed in liver, fat, and muscle tissues, where it controls rates of *de novo* lipogenesis in response to metabolic cues such as insulin and dietary carbohydrate. SREBP-1c function is modulated by proteolytic cleavage, post-translational modification, and transcriptional regulation by hormones and sterol metabolites. Its dysregulation plays a central role in conditions like non-alcoholic fatty liver disease, insulin resistance, and metabolic syndrome [1][4][5][6][7].
Inhibition of SREBP-1c expression (e.g. by statins/compactin) to reduce lipogenesis; Modulation of SREBP-1c activation (e.g. LXR/PPARα agonists upregulate SREBP-1c transcription); Downregulation by glucagon; Upregulation by insulin (used experimentally or via metabolic intervention) [1][3][5][6]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol regulatory element-binding protein 1-c (SREBP-1c).